Glucagon-like peptide-1/glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: A randomized trial.
Karen D CorbinElvis A CarneroTimothy D AllertonJoachim TillnerChristopher P BockPierre-Philippe LuyetBritta GöbelKevin D HallStephanie A ParsonsEric RavussinSteven R SmithPublished in: Obesity (Silver Spring, Md.) (2023)
SAR425899 led to reduced selective metabolic adaptation and increased lipid oxidation, which are believed to be beneficial for weight loss and weight-loss maintenance.